📰 Skye Bioscience News
Page 6 - Skye Bioscience News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Skye Bioscience. Real-time updates on events, politics, business and more.
January 31, 2023
Skye Bioscience Inc (OTCQB:SKYE) said it has received a positive recommendation following a pre-specified data review by the safety review committee (SRC)...
December 21, 2022
Skye Bioscience Chairman & CEO Punit Dhillon joins Natalie Stoberman from the Proactive newsroom to share the announcement of its SBI-100 OE glaucoma...
December 2, 2022
Skye Bioscience CEO Punit Dhillon joins Natalie Stoberman in the Proactive studio to share Novembers milestones. Dhillon says the company has submitted an...
November 22, 2022
San Diego, California--(Newsfile Corp. - November 22, 2022) - Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye" or the "Company"), a pharmaceutical company developing a proprietary, synthetic cannabinoid derivative
November 7, 2022
Skye will continue to pursue Canadian Securities Exchange listing following closing of transaction Vancouver, British Columbia--(Newsfile Corp. - November 7, 2022) - Emerald Health Therapeutics, Inc.
September 30, 2022
Additional capital from Arrangement Agreement expected to fund Skye's Phase 1 and 2 clinical studies of proprietary synthetic cannabinoid-derivative therapeutic targeting glaucoma San Diego, California--(Newsfile
September 2, 2022
A glance at some of the days highlights from the Proactive Investors US and Canada newswires
September 1, 2022
A glance at some of the days highlights from the Proactive Investors US and Canada newswires
September 1, 2022
A glance at some of the days highlights from the Proactive Investors US and Canada newswires
August 19, 2022
Vancouver, British Columbia--(Newsfile Corp. - August 19, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the "Company") reports that its shareholders voted in favour